PM Modi chairs meeting on Corona Vaccine
Indian vaccine companies are well known for their quality, manufacturing capacity and global presence.
Today in addition, they have come across as innovators in early stage vaccine development research.
Similarly, Indian academia and start-ups have also pioneered in this area. Over 30 Indian vaccines are in different stages of corona vaccine development, with a few going on to the trial stages.
Similarly, in drug development three approaches are being taken. First, the repurposing of existing drugs.
At least four drugs are undergoing synthesis and examination in this category.
Secondly, the development of new candidate drugs and molecules are being driven by linking high performance computational approached with laboratory verification.
Thirdly, plant extracts and products are being examined for general anti-viral properties.
The review by the PM took note of the extraordinary coming together of academia, industry and government, combined with speedy but efficient regulatory process.
The PM desired that such coordination and speed should be embedded into a standard operating procedure. He emphasized that what is possible in a crisis should be a part of our routine way of scientific functioning.